| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.084 | 0.09 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.083 | 0.1 |